Chronic Kidney Disease

News Chronic Kidney Disease

• Keryx Biopharmaceuticals Initiates Phase 2 Study of Zerenex for the Treatment of Non-Dialysis Dependent Chronic Kidney Disease

  Keryx Biopharmaceuticals, Inc. announced the initiation of a Phase 2 study of Zerenex™ (ferric citrate), the Company's ferric iron-based phosphate binder drug candidate, in managing serum phosphorus and iron deficiency in anemic patients with Stage 3 to 5 non-dialysis dependent chronic kidney diseas more

• New NUS spin-off company to develop more accurate kidney disease diagnostic kit

  A new spin-off company from the National University of Singapore (NUS), called Nephron Dx, has recently been set up to develop a more accurate diagnostic kit for the earlier detection of diabetic chronic kidney disease. Nephron Dx aims to enter the multi-billion dollar kidney disease diagnostic mark more

• Hormone predicts which kidney patients might die early

  The blood levels of a particular hormone can help predict which kidney disease patients will develop heart problems, need dialysis, and die prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). Testing for this hormone could identi more

Publications Chronic Kidney Disease

• Temporal development of baroreceptor dysfunction in a rodent model of chronic kidney disease

  Summary autonomic control of the cardiovascular system in chronic kidney disease (CKD) contributes to an increased risk of cardiovascular events. We aimed to determine if and when autonomic dysfunction occurs in a conscious, telemetered, rodent model of CKD. In Lewis Polycystic Kidney (LPK; more

• Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction

  by Anna Witasp, Mikael Rydén, Juan Jesús Carrero, Abdul Rashid Qureshi, Louise Nordfors, Erik Näslund, Folke Hammarqvist, Samsul Arefin, Karolina Kublickiene, Peter Stenvinkel Elevated systemic pentraxin 3 (PTX3) levels appear to be a powerful marker of inflammatory status and a superior outcome more

• Vitamin K: key vitamin in controlling vascular calcification in chronic kidney disease

  Vitamin K: key vitamin in controlling vascular calcification in chronic kidney disease Kidney International 83, 782 (May 2013). doi:10.1038/ki.2013.26 Author: Leon J Schurgers more

Market studies Chronic Kidney Disease

• Erythropoietin (EPO) Market Report: 2012 Edition

  With the advent of novel technology, companies operating in the healthcare/science/pharmaceutical/therapeutic area are now scaling new heights. Also this industry is boosted by the rising number of incidences of health related issues emanating from the changing lifestyle and rapidly evolving surroun more

• Global Hyperphosphatemia Drugs Market 2011-2015

  TechNavio's analysts forecast the Global Hyperphosphatemia Drugs market to grow at a CAGR of 12.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of chronic kidney disease. The Global Hyperphosphatemia Drugs market has also be more

• Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2012', provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Kidney Dis more

Websites Chronic Kidney Disease